Press Releases and Coverage

Crown Use Request on T-DM1 in the UK

Press Release

“Coalition for Affordable T-DM1 Asks the Government to Employ Crown Use Authority to Lower Price of Expensive Cancer Drug.”

Press Coverage

01 October 2015. Sarah Boseley. “Health secretary urged to tear up patent on breast cancer drug” The Guardian

01 October 2015. Glyn Moody. “Cancer patients call for UK government to override patent on  a £90,000-a-year drug” Ars Technica UK

01 October 2015. Ben Hirschler. “Call for Britain to over-ride patents on Roche cancer drug” Reuters

01 October 2015. Ed Silverman. “UK patients want government to override Roche patent on cancer drug.” Stat Pharmalot

01 October 2015. Emily Wasserman. “U.K. patient group demands government override Roche’s Kadcyla patents” FiercePharma

01 October 2015. Joe Barber. “Group calls for UK to grant compulsory licence for Roche’s breast cancer drug Kadcyla.” FirstWord Pharma

02 October 2015. “Pressure group seeks compulsory license for biosimilar of Roche’s Kadcyla in UK.” The Pharma Letter


Compulsory licensing in Romania

18 March 2015. Press release concerning Romania compulsory licencing of HCV patents. (pdf), (html)